TriSalus Life Sciences, Inc. Common Stock

ALUS, a charitable organization, has awarded the 2024 Dave Reid Award to François Allard for his exceptional leadership in agricultural stewardship. Victor Drury and Brian Maloney were recognized as runners-up for their outstanding work in environmental conservation and community engagement.

Related tickers: TLSI, TLSIW.

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday. Avinger, Inc. (NASDAQ: AVGR) gained 63.9% to $9.95, adding to outsized gains from Monday. On Monday, Avinger shares soared 46.8% after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device. Sezzle Inc. (NASDAQ: SEZL) shares climbed 46.6% to $18.95. PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) rose 30% to $5.17. Elutia Inc. (NASDAQ: ELUT) shares gained 29.1% to $1.6006 after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics LLC. Elutia announced $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share. Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) surged 24.4% to $10.50. The FDA granted an investigational device exemption to initiate BACKBEAT Study evaluating Orchestra biomed's atrioventricular interval modulation therapy (BACKBEAT CNT) for hypertensive patients who are indicated for a dual-chamber cardiac pacemaker. Rackspace Technology, Inc. (NASDAQ: RXT) gained 20.2% to $1.78 after Raymond James upgraded the stock from Market Perform to Outperform and announced a $3.5 price target. Eos Energy Enterprises, Inc. (NASDAQ: EOSE) jumped 16.6% to $2.65. Neptune Wellness Solutions Inc. (NASDAQ: NEPT) rose 15% to $5.32 after falling 18% on Monday. Neptune Wellness announced intention to spinout Sprout Organics pursuant to the Morgan Stanley agreed to transaction. Solowin Holdings (NASDAQ: SWIN) climbed 14.8% to $2.3882. Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) gained 13.5% to $0.1048. Galera Therapeutics, Inc. (NASDAQ: GRTX) shares rose 13.2% to $0.2158. Galera scheduled a Type A meeting with the FDA to discuss next steps for its radiotherapy avasopasem. Lichen China Limited (NASDAQ: LICN) gained 11.6% to $1.15. TriSalus Life Sciences, ...

Related tickers: SWIN, AUR, CVNA, LLAP, EBIX, NVOS, CNXA, NEPT, CDLX, PROK, SMTC, EQX, LICN, STEM, AXLA, AMPX, ARM, NIO, LIFW, OBIO, TSP, GRTX, CATX, IRWD, SLQT, SXTP, NAVB, HSTO, PHXM, WORX, RXT, TLSI, VSTA, EOSE, SEZL, RVNC, NBTX, ELUT, TTOO, DTOC, AVGR, WALD, CNDT, RKLB.